PART I . Overview We are transforming the way therapeutics and materials are discovered. Our differentiated, physics-based computational platform enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at a lower cost, compared to traditional methods. Our software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. We are applying our computational plat...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001490978-26-000010 | EDGAR | 130K words |
| 2025-02-26 | 2024-12-31 | 0001490978-25-000014 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0001490978-24-000018 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0001490978-23-000024 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001564590-22-006713 | EDGAR | — |
| 2021-03-04 | 2020-12-31 | 0001564590-21-010727 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001564590-20-011182 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001490978-25-000117 | EDGAR | 76K words |
| 2025-08-06 | 2025-06-30 | 0001490978-25-000100 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0001490978-25-000059 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001490978-24-000089 | EDGAR | — |
| 2024-07-31 | 2024-06-30 | 0001490978-24-000072 | EDGAR | — |
| 2024-05-01 | 2024-03-31 | 0001490978-24-000046 | EDGAR | — |
| 2023-11-01 | 2023-09-30 | 0001490978-23-000109 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0001490978-23-000090 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001490978-23-000048 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001490978-22-000012 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001564590-22-028010 | EDGAR | — |
| 2022-05-04 | 2022-03-31 | 0001564590-22-017856 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-12 | 0001490978-26-000013 | EDGAR | 1K words |
| 2026-02-25 | 0001490978-26-000009 | EDGAR | — |
| 2025-11-05 | 0001490978-25-000116 | EDGAR | — |
| 2025-09-08 | 0001490978-25-000106 | EDGAR | — |
| 2025-08-06 | 0001490978-25-000099 | EDGAR | — |
| 2025-06-18 | 0001490978-25-000082 | EDGAR | — |
| 2025-05-20 | 0001193125-25-122800 | EDGAR | — |
| 2025-05-19 | 0001193125-25-122461 | EDGAR | — |
| 2025-05-07 | 0001490978-25-000058 | EDGAR | — |
| 2025-04-11 | 0001490978-25-000034 | EDGAR | — |
85 total filings indexed. 56 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001490978 |
| Ticker | SDGR |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.schrodinger.com |
| Listed | 2020-02-06 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report